The study objective was to investigate the effects of fluoride on intact parathyroid hormone (iPTH) secretion. Thyro-parathyroid complexes (TPC) from C3H (n = 18) and B6 (n = 18) mice were cultured in Ca2+-optimized medium. TPC were treated with 0, 250, or 500 µM NaF for 24 h and secreted iPTH assayed by ELISA. C3H (n = 78) and B6 (n = 78) mice were gavaged once with distilled or fluoride (0.001 mg [F-]/g of body weight) water. At serial time points (0.5-96 h) serum iPTH, fluoride, total calcium, phosphorus, and magnesium levels were determined. Expression of genes involved in mineral regulation via the bone-parathyroid-kidney (BPK) axis, such as parathyroid hormone (Pth), calcium-sensing receptor (Casr), vitamin D receptor (Vdr), parathyroid hormone-like hormone (Pthlh), fibroblast growth factor 23 (Fgf23), α-Klotho (αKlotho), fibroblast growth factor receptor 1c (Fgf1rc), tumor necrosis factor 11 (Tnfs11), parathyroid hormone receptor 1 (Pth1r), solute carrier family 34 member 1 (Slc34a1), solute carrier 9 member 3 regulator 1 (Slc9a3r1), chloride channel 5 (Clcn5), and PDZ domain-containing 1 (Pdzk1), was determined in TPC, humeri, and kidneys at 24 h. An in vitro decrease in iPTH was seen in C3H and B6 TPC at 500 µM (p < 0.001). In vivo levels of serum fluoride peaked at 0.5 h in both C3H (p = 0.002) and B6 (p = 0.01). In C3H, iPTH decreased at 24 h (p < 0.0001), returning to baseline at 48 h. In B6, iPTH increased at 12 h (p < 0.001), returning to baseline at 24 h. Serum total calcium, phosphorus, and magnesium levels did not change significantly. Pth, Casr, αKlotho, Fgf1rc, Vdr, and Pthlh were significantly upregulated in C3H TPC compared to B6. In conclusion, the effects of fluoride on TPC in vitro were equivalent between the 2 mouse strains. However, fluoride demonstrated an early strain-dependent effect on iPTH secretion in vivo. Both strains demonstrated differences in the expression of genes involved in the BPK axis, suggesting a possible role in the physiologic handling of fluoride.

Keywords:
Fluoride, Skeletal fluorosis, Parathyroid hormone, Bone, Inbred mouse strains
1.
Bergwitz, C., H. Juppner (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61: 91-104.
2.
Chen, C., D.N. Kalu (1999) Strain differences in bone density and calcium metabolism between C3H/HeJ and C57BL/6J mice. Bone 25: 413-420.
3.
Ekstrand, J., G. Alvan, L.O. Boreus, A. Norlin (1977) Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol 12: 311-317.
4.
Ekstrand, J., M. Ehrnebo, G.M. Whitford, P.O. Jarnberg (1980) Fluoride pharmacokinetics during acid-base balance changes in man. Eur J Clin Pharmacol 18: 189-194.
5.
Everett, E.T. (2011) Fluoride's effects on the formation of teeth and bones, and the influence of genetics. J Dent Res 90: 552-560.
6.
Gupta, S.K., T.I. Khan, R.C. Gupta, A.B. Gupta, K.C. Gupta, P. Jain, A. Gupta (2001) Compensatory hyperparathyroidism following high fluoride ingestion - a clinico-biochemical correlation. Indian Pediatr 38: 139-146.
7.
Harinarayan, C.V., N. Kochupillai, S.V. Madhu, N. Gupta, P.J. Meunier (2006) Fluorotoxic metabolic bone disease: an osteo-renal syndrome caused by excess fluoride ingestion in the tropics. Bone 39: 907-914.
8.
Imanishi, M., T. Dote, H. Tsuji, E. Tanida, E. Yamadori, K. Kono (2009) Time-dependent changes of blood parameters and fluoride kinetics in rats after acute exposure to subtoxic hydrofluoric acid. J Occup Health 51: 287-293.
9.
Koroglu, B.K., I.H. Ersoy, M. Koroglu, A. Balkarli, S. Ersoy, S. Varol, M.N. Tamer (2011) Serum parathyroid hormone levels in chronic endemic fluorosis. Biol Trace Elem Res 143: 79-86.
10.
Kurland, E.S., R.C. Schulman, J.E. Zerwekh, W.R. Reinus, D.W. Dempster, M.P. Whyte (2007) Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res 22: 163-170.
11.
Li, R., P.K. DenBesten (1993) Expression of bone protein mRNA at physiological fluoride concentrations in rat osteoblast culture. Bone Miner 22: 187-196.
12.
Linkhart, T.A., S.G. Linkhart, Y. Kodama, J.R. Farley, H.P. Dimai, K.R. Wright, J.E. Wergedal, M. Sheng, W.G. Beamer, L.R. Donahue, C.J. Rosen, D.J. Baylink (1999) Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities. J Bone Miner Res 14: 39-46.
13.
Livak, K.J., T.D. Schmittgen (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408.
14.
Nair, M., Z.R. Belak, N. Ovsenek (2011) Effects of fluoride on expression of bone-specific genes in developing Xenopus laevis larvae. Biochem Cell Biol 89: 377-386.
15.
Nakajima, K., T. Okazaki, T. Okamoto, H. Kimura, K. Takano, K. Sato (2010) Genes up- or down-regulated by high calcium medium in parathyroid tissue explants from patients with primary hyperparathyroidism. Endocr J 57: 153-159.
16.
Nielsen, P.K., U. Feldt-Rasmussen, K. Olgaard (1996) A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 11: 1762-1768.
17.
Pei, J., B. Li, Y. Gao, Y. Wei, L. Zhou, H. Yao, J. Wang, D. Sun (2012) Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression. Environ Toxicol 29: 588-595.
18.
Potts, J.T. (2005) Parathyroid hormone: past and present. J Endocrinol 187: 311-325.
19.
Santoyo-Sanchez, M.P., M. del Carmen Silva-Lucero, L. Arreola-Mendoza, O.C. Barbier (2013) Effects of acute sodium fluoride exposure on kidney function, water homeostasis, and renal handling of calcium and inorganic phosphate. Biol Trace Elem Res 152: 367-372.
20.
Teotia, S.P., M. Teotia (1973) Secondary hyperparathyroidism in patients with endemic skeletal fluorosis. Br Med J 1: 637-640.
21.
Teotia, M., S.P. Teotia, K.P. Singh (1998) Endemic chronic fluoride toxicity and dietary calcium deficiency interaction syndromes of metabolic bone disease and deformities in India: year 2000. Indian J Pediatr 65: 371-381.
22.
Torres, P.A., D.P. De Brauwere (2011) Three feedback loops precisely regulating serum phosphate concentration. Kidney Int 80: 443-445.
23.
Turner, C.H., Y.F. Hsieh, R. Muller, M.L. Bouxsein, D.J. Baylink, C.J. Rosen, M.D. Grynpas, L.R. Donahue, W.G. Beamer (2000) Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res 15: 1126-1131.
24.
Turner, C.H., Y.F. Hsieh, R. Muller, M.L. Bouxsein, C.J. Rosen, M.E. McCrann, L.R. Donahue, W.G. Beamer (2001) Variation in bone biomechanical properties, microstructure, and density in BXH recombinant inbred mice. J Bone Miner Res 16: 206-213.
25.
Vogel, G.L., C.M. Carey, L.C. Chow, J. Ekstrand (1990) Fluoride analysis in nanoliter- and microliter-size fluid samples. J Dent Res 69: 522-528, discussion 556-527.
26.
Wang, Y., Y. Yin, L.A. Gilula, A.J. Wilson (1994) Endemic fluorosis of the skeleton: radiographic features in 127 patients. AJR Am J Roentgenol 162: 93-98.
27.
Whitford, G.M. (1994) Intake and metabolism of fluoride. Adv Dent Res 8: 5-14.
28.
Whyte, M.P., W.G. Totty, V.T. Lim, G.M. Whitford (2008) Skeletal fluorosis from instant tea. J Bone Miner Res 23: 759-769.
29.
Wongsurawat, N., H.J. Armbrecht (1987) Comparison of calcium effect on in vitro calcitonin and parathyroid hormone release by young and aged thyroparathyroid glands. Exp Gerontol 22: 263-269.
30.
Xu, H., Q.Y. Liu, J.M. Zhang, H. Zhang, G.S. Li (2010) Elevation of PTH and PTHrp induced by excessive fluoride in rats on a calcium-deficient diet. Biol Trace Elem Res 137: 79-87.
31.
Yan, D., A. Gurumurthy, M. Wright, T.W. Pfeiler, E.G. Loboa, E.T. Everett (2007) Genetic background influences fluoride's effects on osteoclastogenesis. Bone 41: 1036-1044.
32.
Yuan, J.S., A. Reed, F. Chen, C.N. Stewart Jr (2006) Statistical analysis of real-time PCR data. BMC Bioinformatics 7: 85.
33.
Zierold, D., M. Chauviere (2012) Hydrogen fluoride inhalation injury because of a fire suppression system. Mil Med 177: 108-112.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.